Details for Patent: 9,861,644
Which drugs does patent 9,861,644 protect, and when does it expire?
Patent 9,861,644 protects RAYALDEE and is included in one NDA.
This patent has eighty-one patent family members in thirty-six countries.
Summary for Patent: 9,861,644
| Title: | Stabilized modified release vitamin D formulation and method of administering same |
| Abstract: | A stabilized formulation for controlled release of a vitamin D compound is disclosed. The formulation comprises one or both of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 and a cellulosic compound. The stabilized formulations exhibit a stable dissolution profile following exposure to storage conditions and demonstrate improved pharmacokinetic parameters compared to unstabilized formulations. |
| Inventor(s): | Jay A. White, Samir P. Tabash, Sammy A. Agudoawu, Joel Z. Melnick |
| Assignee: | Opko IP Holdings II Inc , Eirgen Pharma Ltd |
| Application Number: | US14/213,285 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 9,861,644
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eirgen | RAYALDEE | calcifediol | CAPSULE, EXTENDED RELEASE;ORAL | 208010-001 | Jun 17, 2016 | RX | Yes | Yes | 9,861,644 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,861,644
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2968172 | ⤷ Start Trial | 122021000009 | Germany | ⤷ Start Trial |
| European Patent Office | 2968172 | ⤷ Start Trial | 301095 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2968172 | ⤷ Start Trial | CA 2021 00005 | Denmark | ⤷ Start Trial |
| European Patent Office | 2968172 | ⤷ Start Trial | 132021000000074 | Italy | ⤷ Start Trial |
| European Patent Office | 2968172 | ⤷ Start Trial | SPC/GB20/043 | United Kingdom | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
